Tredegar TG Transaction expenses
Transaction expenses at other companies
Other financials
Where this comes from
Reported directly by Tredegar in its filing.
Tagged under the XBRL concept tg:DisposalGroupIncludingDiscontinuedOperationTransactionExpenses.
The source filing: Tredegar’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 8:19 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054593
On November 1, 2024, Tredegar completed the sale of Terphane to Oben. At closing, Tredegar received $60 million in cash, which was net of Terphane debt assumed by Oben of $20 million and estimated Terphane cash retained by Oben of $2 million. The cash proceeds received by Tredegar at closing were after deducting net working capital adjustments and closing indebtedness ($20.5 million), escrow funds ($19.8 million), projected Brazil withholding taxes ($10.8 million), and transaction expenses ($4.4 million). In February 2025 and February 2026, the Company received $9.8 million and $0.6 million, respectively, from post-closing settlement of the transaction. The proceeds from the sale of Terphane were required to be used to pay down debt outstanding under the Company’s $125 million senior secured asset-based revolving credit facility (the "ABL Facility").
Item 1. Financial Statements.
FAQ
- What is Tredegar's transaction expenses?
- Tredegar (TG) reported transaction expenses of $4.4M in Q4 2024.
- What does transaction expenses mean?
- Transaction expenses as reported by Tredegar Corporation.
Ask your AI about Tredegar's transaction expenses.
Connect your AI assistant and compare it to peers, right in your chat.
